Research Articles | Page 25 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Current state of prognostication and risk stratification in myelodysplastic syndromes Mar 2015 Curr Opin Hematol myelodysplastic syndromes (MDS)
Current State of the Art: Management of Higher Risk Myelodysplastic Syndromes Aug 2016 Clin Lymphoma Myeloma Leuk. myelodysplastic syndromes (MDS)
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes May 2023 Current Treatment Options in Oncology myelodysplastic syndromes (MDS)
Current therapy of myelodysplastic syndromes. Jul 2013 Blood Rev myelodysplastic syndromes (MDS)
Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society of Blood and Marrow Transplantation May 2023 Haematologica aplastic anemia
Cutting edge: flow cytometry in myelodysplastic syndromes Jul 2013 J Natl Compr Canc Netw myelodysplastic syndromes (MDS)
Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies Mar 2015 Curr Opin Hematol myelodysplastic syndromes (MDS)
Cyclophosphamide in severe aplastic anemia? Oct 2014 Blood aplastic anemia
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro Jun 2020 Experimental Hematology acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro May 2020 Experimental Hematology myelodysplastic syndromes (MDS)
Share with addtoany.com.